<code id='2316EBEF13'></code><style id='2316EBEF13'></style>
    • <acronym id='2316EBEF13'></acronym>
      <center id='2316EBEF13'><center id='2316EBEF13'><tfoot id='2316EBEF13'></tfoot></center><abbr id='2316EBEF13'><dir id='2316EBEF13'><tfoot id='2316EBEF13'></tfoot><noframes id='2316EBEF13'>

    • <optgroup id='2316EBEF13'><strike id='2316EBEF13'><sup id='2316EBEF13'></sup></strike><code id='2316EBEF13'></code></optgroup>
        1. <b id='2316EBEF13'><label id='2316EBEF13'><select id='2316EBEF13'><dt id='2316EBEF13'><span id='2316EBEF13'></span></dt></select></label></b><u id='2316EBEF13'></u>
          <i id='2316EBEF13'><strike id='2316EBEF13'><tt id='2316EBEF13'><pre id='2316EBEF13'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:9592
          Person wearing a blue glove holding money against a blue backdrop.
          Adobe

          WASHINGTON — Medicare officials are moving forward with a plan to claw back money from certain hospitals to try to remedy overpayments struck down by the Supreme Court, they announced Thursday.

          A federal court ordered the Department of Health and Human Services to compensate hospitals that receive discounted drugs through the 340B program for billions of dollars of underpayments, but the money had already gone out to hospitals that didn’t participate in the program.

          advertisement

          Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in the drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Medicare drug price negotiation hearing pits pharma v Biden admin
          Medicare drug price negotiation hearing pits pharma v Biden admin

          AdobeTRENTON,N.J.—PharmaindustrygiantsincludingBristolMyersSquibb,Johnson&Johnson,Novartis,andNo

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          AstraZeneca loses challenge to Medicare drug price negotiation

          ANDREWYATES/AFPviaGettyImagesWASHINGTON—AfederaljudgeinDelawareonFridayruledagainstAstraZenecainacas